NIH bid to tackle reproducibility crisis – is data sharing the answer?
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
How to assess the credibility of clinical trial findings?
Read about Cochrane reviewers’ approaches to detecting and tackling potential fraud in clinical trial publications.
Female and nonbinary scholars call for socially just practices in scientific publishing
Read about the proposed actions to increase social justice in scientific publishing.
Should peer reviewer identities be revealed?
Read about the pros and cons of disclosing reviewer identities as part of the open review process.
Is it time to rewrite the rules on duplicate submission in the age of preprints?
Preprints have changed the way that authors can receive feedback on their manuscript; but when does it verge on ‘unethical’ duplicate peer review?
Meeting report: summary of Day 1 of the 2022 ISMPP European Meeting
Missed the meeting? Read our report to get up to speed!
Is health research no longer to be trusted?
Learn why one expert thinks it’s time to assume all clinical research is fraudulent until there is evidence to the contrary.
Are Registered Reports living up to expectations?
Find out how research published in Registered Reports compares to that in standard articles – is it really higher quality?
Are data availability statements slowing down publication processes?
Read the results of a pilot study on the impact of data availability statements on publication workflows.
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Detectives are on the hunt for fake research papers: Nature analysis investigates the paper mill problem
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
Codes of conduct for research integrity: are they fit for purpose?
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.
Combatting research integrity breaches: insights from Suzanne Farley, Director of the Springer Nature Research Integrity Group
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Research integrity in the COVID-19 era: insights from Retraction Watch co-founder Ivan Oransky
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.